Upcoming Conference Call for Year-End Financial Results
Knight Therapeutics Inc. (TSX: GUD), a well-regarded specialty pharmaceutical company with a focus on the Americas (excluding the USA), is gearing up to unveil its fourth quarter and year-end financial results for the year 2024 on an exciting upcoming date.
Date and Time of the Conference Call
The announcement is set to be made public on a Thursday, and all market participants and stakeholders are invited to join in the discussion. The company aims to create an opportunity for everyone to hear the latest on their financial performance.
Details of the Conference Call
This eagerly anticipated event will take place at 8:30 a.m. ET. For those wishing to participate, the call can be accessed via telephone. Interested parties can dial in toll-free or through international lines, as outlined by the company.
Accessing the Live Webcast
In addition to the phone call, the conference will also be available as an audio webcast. This allows attendees to follow along conveniently from their devices, making it easy to stay informed.
Replay Availability
Can't make it to the live session? No worries! Knight Therapeutics has arranged to offer an archived replay of this webcast, which will be accessible for a period of 30 days following the event. This ensures that even those with busy schedules will have an opportunity to catch up on the important developments at Knight.
What to Expect from Knight Therapeutics
As a robust player in the specialty pharmaceutical field, Knight Therapeutics continues to focus on acquiring and commercializing pharmaceutical products tailored for the Canadian and Latin American markets. Their strategic positioning is supported by subsidiaries operating under the names United Medical, Biotoscana Farma, and Laboratorio LKM.
Company Contact Information
For any inquiries related to the upcoming conference call or the company in general, stakeholders can reach out directly to Knight Therapeutics' dedicated investor relations team. Samira Sakhia, the President and Chief Executive Officer, alongside Arvind Utchanah, Chief Financial Officer, are key contacts for the public.
Frequently Asked Questions
When is the conference call scheduled?
The conference call is scheduled for Thursday morning at 8:30 a.m. ET.
How can I access the live audio webcast?
The live audio webcast can be accessed through the company's official website, where it will be streamed for all participants.
Will there be a replay of the conference call?
Yes, an archived replay will be available on the company's website for 30 days after the event.
Where can I find more information about Knight Therapeutics?
More information can be found on Knight Therapeutics' official website and their corporate communications.
Who can I contact for investor-related questions?
For investor inquiries, you can contact Samira Sakhia or Arvind Utchanah at Knight Therapeutics directly via phone or email.